(Q58145237)

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Mechanisms for insulin resistance: common threads and missing links

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Regulation and function of triacylglycerol lipases in cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F19768354.2014.906502